New perspectives in human stem cell therapeutic research

BMC Medicine

Volumn 7, Issue , 2009, Pages

  Trounson, Alan ^a  

^a California Institute for Regenerative Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADAPTIVE IMMUNITY; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BRAIN TUMOR; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; ISCHEMIC HEART DISEASE; LEUKAPHERESIS; LYSOSOME STORAGE DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURAL STEM CELL TRANSPLANTATION; NOTE; PLURIPOTENT STEM CELL TRANSPLANTATION; RETINA MACULA AGE RELATED DEGENERATION; SAFETY; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TISSUE REGENERATION; TREATMENT INDICATION; TREATMENT RESPONSE; HEALTH CARE POLICY; LEGAL ASPECT; MEDICAL RESEARCH; REGENERATIVE MEDICINE; REVIEW; STEM CELL; UNITED STATES;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HEALTH POLICY; HUMANS; REGENERATIVE MEDICINE; STEM CELLS; UNITED STATES;

EID: 67650150113     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-7-29     Document Type: Note

References (31)

1. Kovacic JC Macdonald P Feneley MP Muller DW Freund J Dodds A Milliken S Tao H Itescu S Moore J Ma D Graham RM Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial Am Heart J 2008, 156:954-963. 10.1016/ j.ahj.2008.04.034 19061712
2. Dill T Schächinger V Rolf A Möllmann S Thiele H Tillmanns H Assmus B Dimmeler S Zeiher AM Hamm C Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: Results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy Am Heart J 2009, 157:541-547. 10.1016/j.ahj.2008.11.011 19249426
3. Sekiguchi H Ii M Losordo DW The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia Am J Physiol Cell Physiol 2009, 219:235-242.
4. Koga H Engebretsen L Brinchmann JE Muneta T Sekiya I Mesenchymal stem cell-based therapy for cartilage repair: A review Knee Surg Sports Traumatol Arthrosc 2009. 19333576
5. Brooke G Rossetti T Pelekanos R Ilic N Murray P Hancock S Antonenas V Huang G Gottlieb D Bradstock K Atkinson K Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials Br J Haematol 2009, 144:571-579. 10.1111/j.1365-2141.2008.07492.x 19077161
6. Moodley Y Atienza D Manuelpillai U Tchongue J Samuel CS Ilancheran S Boyd R Trounson A Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury Am J Path 2009. 19497992
7. Narimatsu H Miyamura K Iida H Hamaguchi M Uchida T Morishita Y Nagoya Blood and Marrow Transplantation Group (NBMTG) Early central nervous complications after umbilical cord blood transplantation for adults Biol Blood Marrow Transplant 2009, 15:92-100. 10.1016/j.bbmt.2008.11.005 19135947
8. Gonzalo-Daganzo R Regidor C Martín-Donaire T Rico MA Bautista G Krsnik I Forés R Ojeda E Sanjuán I García-Marco JA Navarro B Gil S Sánchez R Panadero N Gutiérrez Y García-Berciano M Pérez N Millán I Cabrera R Fernández MN Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults Cytotherapy 2009, 11:278-288. 10.1080/14653240902807018 19308773
9. Burt RK Loh Y Cohen B Stefoski D Balabanov R Katsamakis G Oyama Y Russell EJ Stern J Muraro P Rose J Testori A Bucha J Jovanovic B Milanetti F Storek J Voltarelli JC Burns WH Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: A phase I/II study Lancet Neurol 2009, 8:244-253. 10.1016/ S1474-4422(09)70017-1 19186105
10. Nasef A Ashammakhi N Fouillard L Immunomodulatory effect of mesenchymal stromal cells: Possible mechanisms Int J Lab Hematol 2009, 31:9-19. 10.1111/j.1751-553X.2007.00997.x 19143868
11. Troeger A Meisel R Moritz T Dilloo D Immunotherapy in allogeneic hematopoietic stem cell transplantation - not just a case for effector cells Bone Marrow Transplant 2005(Suppl 1):S59-S64 10.1038/sj.bmt.1704849
12. Le Blanc K Frassoni F Ball L Locatelli F Roelofs H Lewis I Lanino E Sundberg B Bernardo ME Remberger M Dini G Egeler RM Bacigalupo A Fibbe W Ringdén O Developmental Committee of the European Group for Blood and Marrow Transplantation Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study Lancet 2008, 371:1579-1586 10.1016/S0140-6736(08)60690-X 18468541
13. Iyer SS Co C Rojas M Mesenchymal stem cells and inflammatory lung diseases Panminerva Med 2009, 51:5-16 19352305
14. Li M Sun K Welniak LA Murphy WJ Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease Expert Opin Pharmacother 2008, 9:2305-2316 10.1517/14656566.9.13.2305 18710355
15. Crop MJ Baan CC Korevaar SS Ijzermans JN Alwayn IP Weimar W Hoogduijn MJ Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients Transplantation 2009, 87:896-906 10.1097/ TP.0b013e31819b3d72 19300194
16. Torrente Y Polli E Mesenchymal stem cell transplantation for neurodegenerative diseases Cell Transplant 2008, 17:1103-1113 10.3727/ 096368908787236576 19181205
17. England T Martin P Bath PMW Stem cells for enhancing recovery after stroke: A review Int J Stroke 2009, 4:101-110 10.1111/ j.1747-4949.2009.00253.x 19383051
18. Wechsler L Steindler D Borlongan C Chopp M Savitz S Deans R Caplan L Hess D Mays RW Boltze J Boncoraglio G Borlongan CV Caplan LR Carmichael ST Chopp M Davidoff AW Deans RJ Fisher M Hess DC Kondziolka D Mays RW Norrving B Parati E Parent J Reynolds BA Gonzalez-Rothi LJ Savitz S Sanberg P Schneider D Sinden JD et al Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): Bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke Stroke 2009, 40:510-515 19095993
19. Wynn RF Wraith JE Mercer J O'Meara A Tylee K Thornley M Church HJ Bigger BW Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy J Pediatr 2009, 154:609-611 10.1016/ j.jpeds.2008.11.005 19324223
20. Rath P Shi H Maruniak JA Litofsky NS Maria BL Kirk MD Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas Curr Stem Cell Res Ther 2009, 4:44-49 10.2174/157488809787169138 19149629
21. Amariglio N Hirshberg A Scheithauer BW Cohen Y Loewenthal R Trakhtenbrot L Paz N Koren-Michowitz M Waldman D Leider-Trejo L Toren A Constantini S Rechavi G Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient PLoS Med 2009, 6:e1000029 2642879 19226183 10.1371/journal.pmed.1000029
22. Couzin J Biotechnology. Celebration and concern over US trial of embryonic stem cells Science 2009, 323:568 10.1126/science.323.5914.568 19179496
23. Barde Y Caution urged in trial of stem cells to treat spinal-cord injury Nature 2009, 457:516 10.1038/457516a 19177087
24. Hyun I Lindvall O Ahrlund-Richter L Cattaneo E Cavazzana-Calvo M Cossu G De Luca M Fox IJ Gerstle C Goldstein RA Hermerén G High KA Kim HO Lee HP Levy-Lahad E Li L Lo B Marshak DR McNab A Munsie M Nakauchi H Rao M Rooke HM Valles CS Srivastava A Sugarman J Taylor PL Veiga A Wong AL Zoloth L et al New ISSCR guidelines underscore major principles for responsible translational stem cell research Cell Stem Cell 2008, 3:607-609 10.1016/j.stem.2008.11.009 19041777
25. Yamanaka S A fresh look at iPS cells Cell 2009, 137:13-17 10.1016/ j.cell.2009.03.034 19345179
26. Zhou H Wu S Joo JY Zhu S Han DW Lin T Trauger S Bien G Yao S Zhu Y Siuzdak G Schöler HR Duan L Ding S Generation of induced pluripotent stem cells using recombinant protein Cell Stem Cell 2009, 4:381-4 10.1016/j.stem.2009.04.005 19398399
27. Kroon E Martinson LA Kadoya K Bang AG Kelly OG Eliazer S Young H Richardson M Smart NG Cunningham J Agulnick AD D'Amour KA Carpenter MK Baetge EE Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo Nat Biotechnol 2008, 26:397-398 10.1038/nbt1393 18392020
28. Pal R Embryonic stem (ES) cell-derived cardiomyocytes: A good candidate for cell therapy applications Cell Biol Int 2009, 33:325-326 10.1016/ j.cellbi.2008.12.001 19121644
29. Lindvall O Kokaia Z Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease Trends Pharmacol Sci 2009, 30:260-267 10.1016/j.tips.2009.03.001 19362379
30. Basma H Soto-Gutiérrez A Yannam GR Liu L Ito R Yamamoto T Ellis E Carson SD Sato S Chen Y Muirhead D Navarro-Alvarez N Wong RJ Roy-Chowdhury J Platt JL Mercer DF Miller JD Strom SC Kobayashi N Fox IJ Differentiation and transplantation of human embryonic stem cell-derived hepatocytes Gastroenterology 2009, 136:990-999 10.1053/ j.gastro.2008.10.047 19026649
31. Vugler A Carr AJ Lawrence J Chen LL Burrell K Wright A Lundh P Semo M Ahmado A Gias C da Cruz L Moore H Andrews P Walsh J Coffey P Elucidating the phenomenon of HESC-derived RPE: Anatomy of cell genesis, expansion and retinal transplantation Exp Neurol 2008 214 347 361 10.1016/ j.expneurol.2008.09.007 18926821